Literature DB >> 18487311

MD simulations of papillomavirus DNA-E2 protein complexes hints at a protein structural code for DNA deformation.

M Falconi1, F Oteri, T Eliseo, D O Cicero, A Desideri.   

Abstract

The structural dynamics of the DNA binding domains of the human papillomavirus strain 16 and the bovine papillomavirus strain 1, complexed with their DNA targets, has been investigated by modeling, molecular dynamics simulations, and nuclear magnetic resonance analysis. The simulations underline different dynamical features of the protein scaffolds and a different mechanical interaction of the two proteins with DNA. The two protein structures, although very similar, show differences in the relative mobility of secondary structure elements. Protein structural analyses, principal component analysis, and geometrical and energetic DNA analyses indicate that the two transcription factors utilize a different strategy in DNA recognition and deformation. Results show that the protein indirect DNA readout is not only addressable to the DNA molecule flexibility but it is finely tuned by the mechanical and dynamical properties of the protein scaffold involved in the interaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487311      PMCID: PMC2479573          DOI: 10.1529/biophysj.108.130849

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  35 in total

1.  Concerted motions in copper plastocyanin and azurin: an essential dynamics study.

Authors:  C Arcangeli; A R Bizzarri; S Cannistraro
Journal:  Biophys Chem       Date:  2001-03-15       Impact factor: 2.352

Review 2.  The papillomavirus E2 proteins: structure, function, and biology.

Authors:  Rashmi S Hegde
Journal:  Annu Rev Biophys Biomol Struct       Date:  2001-10-25

Review 3.  Force fields for protein simulations.

Authors:  Jay W Ponder; David A Case
Journal:  Adv Protein Chem       Date:  2003

4.  Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target.

Authors:  R S Hegde; S R Grossman; L A Laimins; P B Sigler
Journal:  Nature       Date:  1992-10-08       Impact factor: 49.962

5.  Solution structure of ApaG from Xanthomonas axonopodis pv. citri reveals a fibronectin-3 fold.

Authors:  Daniel O Cicero; Gian M Contessa; Thelma A Pertinhez; Mariana Gallo; Angela M Katsuyama; Maurizio Paci; Chuck S Farah; Alberto Spisni
Journal:  Proteins       Date:  2007-05-01

6.  The dimeric DNA binding domain of the human papillomavirus E2 protein folds through a monomeric intermediate which cannot be native-like.

Authors:  Y K Mok; M Bycroft; G de Prat-Gay
Journal:  Nat Struct Biol       Date:  1996-08

7.  The essential dynamics of Cu, Zn superoxide dismutase: suggestion of intersubunit communication.

Authors:  G Chillemi; M Falconi; A Amadei; G Zimatore; A Desideri; A Di Nola
Journal:  Biophys J       Date:  1997-08       Impact factor: 4.033

8.  Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.

Authors:  D A Francis; S I Schmid; P M Howley
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

9.  Essential dynamics of proteins.

Authors:  A Amadei; A B Linssen; H J Berendsen
Journal:  Proteins       Date:  1993-12

10.  Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains.

Authors:  I Giri; M Yaniv
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  2 in total

1.  Local conformational changes in the DNA interfaces of proteins.

Authors:  Tomoko Sunami; Hidetoshi Kono
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

2.  Protein flexibility directs DNA recognition by the papillomavirus E2 proteins.

Authors:  Craig Brown; Karen Campos-León; Madeleine Strickland; Christopher Williams; Victoria Fairweather; R Leo Brady; Matthew P Crump; Kevin Gaston
Journal:  Nucleic Acids Res       Date:  2010-12-03       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.